Noszczyk-Nowak Agnieszka, Michałek Marcin, Kapturska Karolina, Janiszewski Adrian, Pasławski Robert, Skrzypczak Piotr, Pasławska Urszula
Department of Internal Medicine with Clinic of Diseases of Horses, Dogs, and Cats, Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, 50-366 Wrocław, Poland.
Student of Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland.
J Vet Res. 2019 Mar 22;63(1):133-140. doi: 10.2478/jvetres-2019-0016. eCollection 2019 Mar.
Pacemaker implantation is the only effective symptomatic treatment for life-threatening bradyarrhythmias. Major complications observed after implantation of cardiac pacemakers include lead dislocation, loss of pulse generator function, and inadequate stimulation. The aim of this retrospective single-centre study was to analyse the indications for pacemaker implantation and the incidence and types of complications associated with this procedure in dogs treated for symptomatic bradyarrhythmia.
The retrospective analysis included 31 dogs with symptomatic bradyarrhythmia, implanted with permanent cardiac pacemakers in 1992-2017. The list of analysed variables included patient age, breed, sex, indication for pacemaker implantation, comorbidities, and the incidence of procedure-related complications along with the type thereof.
The most common indication for pacemaker implantation was 3 degree AVB, followed by SSS, advanced 2 degree AVB, and PAS. Pacemaker implantation was associated with a 35% overall complication rate and 6.45% periprocedural mortality. There were no significant differences in terms of procedure-related complications with regard to age, sex, breed, indications for pacemaker implantation, or comorbidities.
Cardiac pacing is the only effective treatment of symptomatic bradycardia, but as an invasive procedure, may pose a risk of various complications, including death.
起搏器植入是治疗危及生命的缓慢性心律失常的唯一有效对症治疗方法。心脏起搏器植入后观察到的主要并发症包括导线脱位、脉冲发生器功能丧失和刺激不足。这项回顾性单中心研究的目的是分析有症状性缓慢性心律失常的犬只起搏器植入的适应证以及与该手术相关的并发症的发生率和类型。
回顾性分析纳入了1992年至2017年间31只植入永久性心脏起搏器的有症状性缓慢性心律失常的犬只。分析的变量包括患者年龄、品种、性别、起搏器植入适应证、合并症以及手术相关并发症的发生率及其类型。
起搏器植入最常见的适应证是三度房室传导阻滞,其次是病态窦房结综合征、高度二度房室传导阻滞和房性早搏。起搏器植入的总体并发症发生率为35%,围手术期死亡率为6.45%。在与手术相关的并发症方面,年龄、性别、品种、起搏器植入适应证或合并症之间没有显著差异。
心脏起搏是有症状性心动过缓的唯一有效治疗方法,但作为一种侵入性手术,可能会带来包括死亡在内的各种并发症风险。